{{chembox
| Watchedfields = changed
| Name=7,12-Dimethylbenz[''a'']anthracene
| verifiedrevid = 477226290
| Reference=<ref>[http://www.sigmaaldrich.com/catalog/search/ProductDetail/SIGMA/D3254 7,12-Dimethylbenz(a)anthracene] {{Wayback|url=http://www.sigmaaldrich.com/catalog/search/ProductDetail/SIGMA/D3254 |date=20080724003229 }} at [[Sigma-Aldrich|Sigma-Aldrich]]</ref>
| ImageFile1=DMBA.png
| ImageFile2=7,12-Dimethylbenz(a)anthracene_ballstick.png
| PIN = 7,12-Dimethyltetraphene
| OtherNames = 7,12-Dimethylbenzo[''a'']phenanthrene<br />7,12-Dimethylbenzanthracene<br />7,12-Dimethyltetraphene<br />1,4-Dimethyl-2,3-benzophenanthrene
|Section1={{Chembox Identifiers
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5779
| InChI = 1/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3
| InChIKey = ARSRBNBHOADGJU-UHFFFAOYAX
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 329673
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ARSRBNBHOADGJU-UHFFFAOYSA-N
| CASNo=57-97-6
| CASNo_Ref = {{cascite|correct|CAS}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = F05B6S0395
| PubChem=6001
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 254496
| SMILES = c32c(c1ccccc1c(c2ccc4c3cccc4)C)C
}}
|Section2={{Chembox Properties
| C=20 | H=16
| Appearance=
| Density=
| MeltingPtC=122 - 123
| BoilingPt=
| Solubility=
  }}
|Section3={{Chembox Hazards
| MainHazards=T (Toxic)
| FlashPt=
| AutoignitionPt =
| RPhrases={{R45}} {{R22}}
| SPhrases={{S53}} {{S36/37}} {{S45}}
| NFPA-H = 2
| NFPA-R = 0
| NFPA-F = 0
| NFPA-S =
  }}
}}

'''7,12-二甲基苯并[''a'']蒽'''（{{lang-en|7,12-Dimethylbenz[''a'']anthracene}}，缩写'''DMBA'''）是一种[[免疫抑制|免疫抑制剂]]和强效的有机[[致癌物質|致癌物質]]<ref>{{cite journal |author=Miyata M |author2=Furukawa M |author3=Takahashi K |author4=Gonzalez FJ |author5=Yamazoe Y |title=Mechanism of 7, 12-Dimethylbenz[a]anthracene-Induced Immunotoxicity: Role of Metabolic Activation at the Target Organ |journal=Jpn J Pharmacol |date=2001 |volume=86 |issue=3 |pages=302–309 |doi=10.1254/jjp.86.302 |pmid=11488430 |doi-access=free }}</ref>。在生物实验室中，DMBA常用于癌症模型的造模，即用DMBA诱导细胞组织[[癌变|癌变]]，可与[[佛波醇-12-十四烷酰-13-乙酸酯|佛波醇-12-''O''-十四烷酰-13-乙酸酯]]（TPA）联合使用来加速癌症模型的研究<ref>{{cite journal | author = Sung YM | author2 = He G | author3 = Fischer, SM | date = 2005 | title =  Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development | journal = Cancer Res | volume = 65 | issue = 20 | pages = 9304–9311 | doi=10.1158/0008-5472.can-05-1015| pmid = 16230392 | doi-access = free }}</ref>。

==参考文献==
{{reflist}}

{{DEFAULTSORT:Dimethylbenz(a)anthracene, 7,12-}}

[[Category:蒽|Category:蒽]]
[[Category:多環芳香烴|Category:多環芳香烴]]
[[Category:致癌物質|Category:致癌物質]]
[[Category:免疫抑制剂|Category:免疫抑制剂]]